IP Library › Assignment 060938/0213
Patent Assignment
Reel/Frame 060938/0213

Assignment of Assignor's Interest

Recorded: 2022-08-30 Pages: 8
Assignors
BELLENIE, BENJAMIN RICHARD
Executed: 2022-06-16
BRENNAN, ALFIE
Executed: 2022-06-12
CHEUNG, KWAI MING JACK
Executed: 2022-06-09
HARNDEN, ALICE CLAIRE
Executed: 2022-06-16
HOELDER, SWEN
Executed: 2022-06-16
DAVIS, OWEN ALEXANDER
Executed: 2022-06-16
HUCKVALE, ROSEMARY
Executed: 2022-05-31
Assignee
THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
123 OLD BROMPTON ROAD, LONDON, ENGLAND, SW7 3RP, UNITED KINGDOM
Covered Property (1)
[1,4]Oxazepino[2,3-C]Quinolinone Derivatives as BCL6 Inhibitors
Application: 17/768,174 →
Publication: US 2024/0217987
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 9, 2025
From: BELLENIE, BENJAMIN RICHARD; BRENNAN, ALFIE; CHEUNG, KWAI MING JACK; DAVIS, OWEN ALEXANDER
To: THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 071646/0715 →